Chinese Pharma Benda Reports 66 Percent Increase In Revenue For 2007
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Benda Pharmaceutical announced a jump in profits for the fourth quarter and fiscal year ended December 31, 2007, mainly due to SiBiono's gross profits of $5.27 million, which Benda acquired in April 2007
You may also be interested in...
China’s MOH-SFDA Merger: Analysts Weigh In
SHANGHAI - China has reorganized the Ministry of Health and put the State FDA under its jurisdiction. The State Council's institutional restructuring scheme was officially approved March 15 at the first session of the 11 National People's Congress held in Beijing
Lucrative Conference: Benda Recognizes $1.3 Million For Gendicine Order
SHANGAHI - Benda has recognized $1.3 million in revenues from an order worth $3.8 million placed at a recent conference for its cancer gene therapy Gendicine, the company announced Dec 5
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).